Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
ASH: Gilead, Novartis tout long-term data for CAR-T slow starters Yescarta, Kymriah
Fierce Pharma
Sun, 12/2/18 - 11:01 pm
Gilead
Novartis
CAR-T
Yescarta
Kymriah
ASH2018
ASH18: Bluebird's follow-on CAR-T finds initial success, but durability will be key test
Biopharma Dive
Sun, 12/2/18 - 10:50 pm
ASH2018
Bluebird Bio
CAR-T
bb21217
ASH18: CAR-T shows up in early CLL test
Biopharma Dive
Sun, 12/2/18 - 10:48 pm
Celgene
CAR-T
CLL
ASH2018
JCAR017
Novartis focusing on cutting CAR-T costs ahead of EU launches
Pharmaforum
Tue, 11/20/18 - 11:51 am
Novartis
CAR-T
Europe
Spotlight co-founder uses CRISPR screen to ID T cell regulator genes for cancer
BioCentury
Sun, 11/18/18 - 12:48 pm
Spotlight Therapeutics
CAR-T
CRISPR
Novartis’ CAR-T cancer drug available on NHS to young people
Pharmaforum
Sat, 11/17/18 - 12:34 pm
Novartis
CAR-T
NHS
refractory B-cell acute lymphoblastic leukemia
Kymriah
June highlights shorter CAR T culture times at SITC
BioCentury
Sun, 11/11/18 - 09:03 pm
CAR-T
SITC
Waiting for bluebird bio to Sing at ASH
Motley Fool
Sat, 11/10/18 - 12:05 pm
Bluebird Bio
earnings
ASH
CAR-T
Parker Institute backs an upstart biotech looking to develop a new, convertible CAR-T
Endpoints
Thu, 10/18/18 - 11:27 pm
CAR-T
Xyphos Biosciences
NHS, Gilead reach agreement for Yescarta
BioCentury
Sat, 10/6/18 - 12:50 pm
Yescarta
Gilead Sciences
UK
NHS
CAR-T
Insight: How Novartis built a ‘money-filled moat’ to market Kymriah
Biopharma Reporter
Thu, 10/4/18 - 06:59 pm
Novartis
Kymriah
competition
drug marketing
CAR-T
Allogene IPO could be year's largest biotech listing on NASDAQ
BioCentury
Tue, 10/2/18 - 07:45 pm
IPOs
NASDAQ
Allogene
CAR-T
Loyola is working on a new and improved CAR-T product, looking to overcome high-frequency side effects
Endpoints
Fri, 09/28/18 - 11:50 am
Loyola University
CAR-T
drug development
NICE rejects Novartis’ CAR-T in adult lymphoma
Pharmaforum
Wed, 09/19/18 - 11:22 pm
NICE
UK
Novartis
CAR-T
Kymriah
NHS
diffuse large B-cell lymphoma
Allogene Therapeutics Announces Filing For IPO
CP Wire
Fri, 09/14/18 - 09:39 am
Allogene
IPOs
CAR-T
Atara brings another experienced investigator onto its off-the-shelf CAR-T quest in latest collaboration
Endpoints
Fri, 09/7/18 - 05:51 pm
Atara
CAR-T
cancer
Novartis CAR-T therapy snags UK coverage, cutting list price 23% from US
Biopharma Dive
Wed, 09/5/18 - 10:01 pm
Novartis
Kymriah
CAR-T
UK
Juno investors eke out $24M settlement in lawsuit over CAR-T trial deaths
Fierce Pharma
Wed, 09/5/18 - 09:58 pm
Juno Therapeutics
JCAR015
CAR-T
UK rejects Gilead's CAR-T cancer cell therapy as too expensive
Reuters
Tue, 08/28/18 - 11:51 am
Yescarta
UK
Europe
CAR-T
NICE
Gilead Sciences
Novartis wins a key OK for Kymriah, but continuing manufacturing woes hobble rollout — rival Gilead CAR-T breaks into Europe
Endpoints
Mon, 08/27/18 - 10:10 am
Novartis
CAR-T
Kymriah
drug manufacturing
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »